{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:09:54Z","timestamp":1792706994198,"version":"4.5.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.7759\/cureus.63592","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:34:50Z","timestamp":1719844490000},"source":"Crossref","is-referenced-by-count":3,"title":["Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period"],"prefix":"10.7759","author":[{"given":"Mari","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4482","article-title":"Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer","volume":"2","author":"Sacher AG","year":"2016","unstructured":"Sacher AG, Dahlberg SE, Heng J, Mach S, J\u00e4nne PA, Oxnard GR. Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer. JAMA Oncol. 2016, 2:313-20. 10.1001\/jamaoncol.2015.4482","journal-title":"JAMA Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.02.005","article-title":"First case report of pregnancy on alectinib in a woman with metastatic ALK-rearranged lung cancer: a case report","volume":"16","author":"Scarfone G","year":"2021","unstructured":"Scarfone G, Fumagalli M, Imbimbo M, et al.. First case report of pregnancy on alectinib in a woman with metastatic ALK-rearranged lung cancer: a case report. J Thorac Oncol. 2021, 16:873-7. 10.1016\/j.jtho.2021.02.005","journal-title":"J Thorac Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107188","article-title":"The safety and efficacy for the treatment of alectinib in a women with ALK-positive lung cancer delivered a healthy male neonate throughout pregnancy: a case report","volume":"180","author":"Shang M","year":"2023","unstructured":"Shang M, Luo X, Wu J, Wang Z, Chen Q, Zhou Y. The safety and efficacy for the treatment of alectinib in a women with ALK-positive lung cancer delivered a healthy male neonate throughout pregnancy: a case report. Lung Cancer. 2023, 180:107188. 10.1016\/j.lungcan.2023.107188","journal-title":"Lung Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.09.001","article-title":"Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma","volume":"161","author":"Boudy AS","year":"2021","unstructured":"Boudy AS, Grausz N, Selleret L, et al.. Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma. Lung Cancer. 2021, 161:68-75. 10.1016\/j.lungcan.2021.09.001","journal-title":"Lung Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2022.100361","article-title":"Two uncomplicated pregnancies on alectinib in a woman with metastatic ALK-rearranged NSCLC: a case report","volume":"3","author":"Weidenbaum C","year":"2022","unstructured":"Weidenbaum C, Cann CG, Osmundson S, Iams WT, Osterman T. Two uncomplicated pregnancies on alectinib in a woman with metastatic ALK-rearranged NSCLC: a case report. JTO Clin Res Rep. 2022, 3:100361. 10.1016\/j.jtocrr.2022.100361","journal-title":"JTO Clin Res Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234995-anaplastic-lymphoma-kinase-tyrosine-kinase-inhibitor-treatment-for-metastatic-non-small-cell-lung-cancer-throughout-the-entire-gestation-period","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:34:53Z","timestamp":1719844493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234995-anaplastic-lymphoma-kinase-tyrosine-kinase-inhibitor-treatment-for-metastatic-non-small-cell-lung-cancer-throughout-the-entire-gestation-period"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.63592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}